Single tumor-associated cell surface antigen

The term 'Single tumor-associated cell surface antigen' is a generic descriptive phrase rather than a specific biological molecule or therapeutic target. It refers to the broad class of proteins, glycoproteins, or glycolipids expressed on the plasma membrane of neoplastic cells that can be recognized by the immune system or targeted by pharmacological interventions such as monoclonal antibodies, antibody-drug conjugates (ADCs), and CAR-T cells (National Cancer Institute, 2023). Common examples of specific targets within this category include HER2, CD20, and EGFR, each of which has a distinct biological function and role in oncogenesis. Because this term describes a functional category rather than a single gene product, it does not possess a unique set of biochemical properties, signaling pathways, or drug interactions. In the context of drug discovery and clinical oncology, a specific molecular target must be identified to define a mechanism of action, safety profile, and patient selection criteria (Abbas et al., 2021). Consequently, this entry represents a conceptual placeholder rather than a distinct, druggable receptor or enzyme.

Other names

Tumor-associated antigenTAACell surface tumor antigenTumor-specific antigen

Not applicable as this is a general category of targets rather than a specific molecular entity.